Tumor-infiltrating lymphocytes are T cells that have naturally migrated into the tumor. TIL therapy involves isolating these cells from the tumor, expanding them ex vivo, and reinfusing them into the patient. This strategy has shown promise, especially in patients with metastatic melanoma.
